Lucas Named Chair of UC's Pathology Department
CINCINNATIThe University of Cincinnati (UC) Board of Trustees Tuesday approved the naming of Fred Lucas, MD, as chair of the department of pathology and laboratory medicine. He also becomes the MacKenzie Chair of Pathology. His appointment is effective July 1, 2012.
Lucas replaces David Witte, MD, who has served as chair since 2007. Witte plans to return to faculty and focus attention on his duties as director of pathology at Cincinnati Childrens Hospital Medical Center.
Lucas is a graduate of the University of Missouri School of Medicine in Columbia, Mo. He completed a fellowship in anatomic and clinical pathology at the Cleveland Clinic Foundation in 1979 and went on to hold a number of positions within Cleveland Clinic and Case Western Reserve University before becoming chairman of the department of pathology and laboratory medicine at the Cleveland Clinic in Florida in 1988.
In 1997, Lucas entered private practice in Cincinnati and then held leadership roles for the medical and transfusion services department at Christ Hospital and Midwest Pathology Group. He joined UCs faculty in 2007 and in 2011 was named vice chair for clinical services and medical director at the UC Health University Hospital Clinical Laboratory.
"Dr. Lucas has been instrumental in the successful effort aimed at bringing anatomic and clinical pathology services back in house at University Hospitalimperative for training, patient care and clinical trial work, said College of Medicine Dean Thomas Boat, MD, in a memo to faculty and staff. "He has been actively involved in recruiting new faculty to the department and has made numerous contributions to the education of pathology residents, clinical fellows and second-year medical students.
Lucas interests include clinical laboratory testing, hematopathology and surgical pathology.
More information about the department of pathology and laboratory medicine can be found at http://www.pathology.uc.edu.
Related Stories
Cancer Center plays key role in lab research, clinical trials for new pancreatic cancer drug
September 1, 2026
WLWT and WCPO highlighted the contributions of University of Cincinnati Cancer Center researchers that helped lead to the recent FDA approval of daraxonrasib, a new treatment for pancreatic cancer.
Cancer Center physician receives $150,000 New Investigator Research Grant to study treatment-resistant leukemia
September 1, 2026
The University of Cincinnati Cancer Center’s Sarah Skuli, MD, PhD, received a two‑year, $150,000 Leukemia Research Foundation New Investigator Grant to study TP53‑mutated leukemia, a treatment‑resistant subtype with very poor outcomes.
Heavy social media use linked to depression
August 31, 2026
U.S. News and World Report, Yahoo! News, MSN, USA Today and other national media highlight a new study by the University of Cincinnati and Northwestern University that found a correlation between heavy social media use and depression in adults.